Key Events This Week
10 Aug: Valuation upgraded to Fair; P/E and P/BV ratios improved
11 Aug: Formation of Golden Cross signalling potential bullish breakout
14 Aug: Week closes at Rs.102.25 (+3.91%) outperforming Sensex
Aug 25, 03:50 PM
BSE+NSE Vol: 7114

Par Drugs & Chemicals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
10 Aug: Valuation upgraded to Fair; P/E and P/BV ratios improved
11 Aug: Formation of Golden Cross signalling potential bullish breakout
14 Aug: Week closes at Rs.102.25 (+3.91%) outperforming Sensex

The 50-day moving average has crossed above the 200-day moving average for Par Drugs & Chemicals Ltd, signalling a golden cross on 11 Jun 2026. Yet, the stock declined 3.02% on the day this crossover occurred, while monthly indicators remain only mildly bullish or neutral. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability.
Read full news article
Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 8 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Read full news article
Par Drugs & Chemicals Ltd has witnessed a significant improvement in its valuation parameters, transitioning from a very expensive rating to a fair valuation grade. This shift, driven primarily by a marked reduction in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positions the micro-cap chemical company as a more attractive proposition relative to its historical levels and peer group benchmarks.
Read full news article
Par Drugs & Chemicals Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, reflecting a positive change in market perception. With a current price of ₹99.30 and a recent day gain of 3.61%, the micro-cap chemical company is showing signs of renewed investor confidence amid a challenging sector backdrop.
Read full news article
Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date view of its performance and outlook.
Read full news article
Par Drugs & Chemicals Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of price multiples such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap chemical company more favourably against its peers and historical benchmarks.
Read full news article
Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news articlePar Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on November 11, 2019.
Par Drugs And Chemicals Limited has informed the Exchange that the Company has fixed Record Date as November 25, 2019 for the purpose of INTERIM DIVIDEND
Par Drugs And Chemicals Limited has informed the Exchange regarding 'WHO-GMP Certification'.
No Upcoming Board Meetings
Par Drugs & Chemicals Ltd has declared 12% dividend, ex-date: 22 Nov 21
No Splits history available
Par Drugs & Chemicals Ltd has announced 1:1 bonus issue, ex-date: 27 Apr 21
No Rights history available